Where the specific rules for the placing on the market in Northern Ireland of medicinal products for human use are suspended, the relevant provisions of Union law listed in Annex 2 to the Protocol should apply again to such medicinal products.
Recital 12, Regulation (EU) 2023/1182
In forcesince 14 Jun 2023